Journal
MEDCHEMCOMM
Volume 5, Issue 12, Pages 1834-1842Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c4md00182f
Keywords
-
Funding
- Australian National Health and Medical Research Council [1043149]
- Independent Research Institutes Infrastructure Support Scheme [361646]
- Victorian State Government Operational Infrastructure Support (OIS) Grant
- Australian Cancer Research Foundation
- Dyson Bequest funding
- Catalyst Therapeutics
Ask authors/readers for more resources
The ability of various functional groups to engage the acetyl-lysine (KAc) binding site within bromo- and extra-terminal domain (BET) protein family members BRD2, BRD3 and BRD4 was evaluated by screening small molecular fragments - coupled to a known arylsulfonamide scaffold - in biochemical inhibition assays. Useful structure activity relationships have been established and novel functional groups that bind to the KAc binding pocket identified. Additional microsomal degradation studies were also undertaken revealing significant differences in metabolic stability between two commonly employed BET inhibitor fragments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available